Sevirumab. Protovir, MSL 109, EV2 7, SDZ MSL 109. [electronic resource]
Producer: 20000616Description: 315-7 p. digitalISSN:- 1174-5886
- Animals
- Antibodies, Monoclonal -- pharmacokinetics
- Antiviral Agents -- therapeutic use
- Bone Marrow Transplantation -- adverse effects
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Cytomegalovirus -- drug effects
- Cytomegalovirus Infections -- prevention & control
- Cytomegalovirus Retinitis -- drug therapy
- Drugs, Investigational -- pharmacokinetics
- Humans
- Microbial Sensitivity Tests
- Rabbits
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.